Anemia and the liver hepatobiliary manifestations of anemia

Clinics in Liver Disease

Volumn 6, Issue 4, 2002, Pages 891-907

  Edwards, Corwin Q ^a  

^a LDS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD59 ANTIGEN; CYANOCOBALAMIN; DECAY ACCELERATING FACTOR; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; GLUCURONOSYLTRANSFERASE; HEPARIN; METHIONINE SYNTHASE; PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE; PHOSPHATIDYLINOSITOL GLYCAN ANCHOR; STREPTOKINASE; TICLOPIDINE; UNCLASSIFIED DRUG; WARFARIN;

ACUTE GRANULOCYTIC LEUKEMIA; AMINO ACID SUBSTITUTION; APLASTIC ANEMIA; APPENDICITIS; AUTOIMMUNE HEPATITIS; AUTOLOGOUS BONE MARROW TRANSPLANTATION; AUTOSOMAL RECESSIVE DISORDER; BETA CHAIN; BILIRUBIN BLOOD LEVEL; BONE MARROW TRANSPLANTATION; BUDD CHIARI SYNDROME; CELL ADHESION; CELL ANCHORAGE; CELL MEMBRANE; CELL PROTECTION; CHINESE; CLINICAL FEATURE; CYTOLYSIS; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DRUG INDUCED DISEASE; ERYTHROCYTE DEFORMABILITY; ERYTHROCYTE LIFESPAN; ERYTHROCYTE SHAPE; GALLSTONE; GENE MUTATION; GENETIC CODE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY; HELLP SYNDROME; HEMOLYTIC ANEMIA; HEPATOBILIARY DISEASE; HEPATOMEGALY; HEREDITARY SPHEROCYTOSIS; HUMAN; LABORATORY TEST; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER DISEASE; LIVER HEMANGIOMA; LIVER INJURY; NUCLEAR MAGNETIC RESONANCE; OBSTRUCTIVE JAUNDICE; PAROXYSMAL NOCTURNAL HEMOGLOBINURIA; PROTEIN FUNCTION; REVIEW; SCLEROSING CHOLANGITIS; SEX DIFFERENCE; SICKLE CELL ANEMIA; SPLENOMEGALY; THAILAND; VEIN OCCLUSION; VIRUS HEPATITIS; X CHROMOSOME;

ANEMIA; ANEMIA, SICKLE CELL; BIOPSY; DIAGNOSIS, DIFFERENTIAL; FEMALE; GLUCOSEPHOSPHATE DEHYDROGENASE DEFICIENCY; HELLP SYNDROME; HEMOGLOBINURIA, PAROXYSMAL; HUMANS; LIVER; LIVER DISEASES; PREGNANCY; SPHEROCYTOSIS, HEREDITARY;

EID: 0036867167     PISSN: 10893261     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1089-3261(02)00050-8     Document Type: Review

References (110)

1. Hebbel RP, Miller WJ. Phagocytosis of sickle erythrocytes: Immunologic and oxidative determinants of hemolytic anemia. Blood 1984;64:733-41.
2. Green TW, Conley CL, Berthrong M. The liver in sickle cell anemia. Johns Hopkins Med J 1953;92:99-122.
3. Klion FM, Weidner MJ, Schaffner F. Cholestasis in sickle cell anemia. Am J Med 1964;37:829-32.
4. Rosenblate HJ, Eisenstein R, Holmes AW. The liver in sickle cell anemia: A clinical-pathological study. Arch Pathol 1970;90:235-45.
5. Brozovic M, Davies SC, Brownell AI. Acute admissions of patients with sickle cell disease who live in Britain. BMJ 1987;294:1206-8.
6. Johnson CS, Omata M, Tong MJ, et al. Liver involvement in sickle cell disease. Medicine (Baltimore) 1985;64:349-56.
7. Powars DR. Natural history of sickle cell disease - The first ten years. Semin Hematol 1975;12:267-85.
8. Buchanan GR, Glader BE. Benign course of extreme hyperbilirubinemia in sickle cell anemia: Analysis of six cases. J Pediatr 1977;91:21-4.
9. Antal P, Gauderer M, Koshy M, et al. Is the incidence of apendicitis reduced in patients with sickle cell disease? Pediatrics 1998;101:E7.
10. Herrick JB. Peculiar elongated and sickle-shaped red corpuscles in a case of severe anemia. Arch Intern Med 1910;6:517.
11. Karayalcin J, Rosner F, Kim KY, et al. Sickle cell anemia-clinical manifestations in 100 patients and review of the literature. Am J Med Sci 1975;269:51-68.
12. Omata M, Johnson CS, Tong M, et al. Pathological spectrum of liver diseases in sickle cell disease. Dig Dis Sci 1986;31:247-56.
13. Schubert TT. Hepatobiliary system in sickle cell disease. Gastroenterology 1986;90:2013-21.
14. Bauer TW, Moore GW, Hutchins GM. The liver in sickle cell disease: A clinicopathologic study of 70 patients. Am J Med 1980;69:833-7.
15. Laulan S, Bernard JF, Boivin P. Systematic blood transfusions in adult homozygote sickle-cell anemia. Presse Med 1990;19:785-9.
16. Miller ST, Jensen D, Rao SP. Less intensive long-term transfusion therapy for sickle cell anemia and cerebrovascular accident. J Pediatr 1992;120:54-7.
17. Conrad ME. Sickle cell disease and hemochromatosis. Am J Hematol 1991;38:150-2.
18. Song YS. Hepatic lesions in sickle cell anemia. Am J Pathol 1957;33:331-44.
19. Barrett-Connor E. Sickle cell disease and viral hepatitis. Ann Intern Med 1968;69:517-27.
20. Phillips JC, Gerald BE. The incidence of cholelithiasis in sickle cell disease. Am J Roentgenol 1971;113:27-8.
21. McCall IW, Desai P, Serjeant BE, et al. Cholelithiasis in Jamaican patients with homozygous sickle cell disease. Am J Hematol 1977;3:15-21.
22. Sarnaik S, Slovis TL, Corbett DP, et al. Incidence of cholelithiasis in sickle cell anemia using the ultrasonic gray-scale technique. J Pediatr 1980;96:1005-8.
23. Everson GT, Nemeth A, Kourourian S, et al. Gallbladder function is altered in sickle hemoglobinopathy. Gastroenterology 1989;96:1307-16.
24. Soloway RD, Trotman BW, Ostrow JD. Progress in gastroenterology: Pigment gallstones. Gastroenterol 1977;72:167-82.
25. Trotman BW, Soloway RD. Pigment gallstone disease: Summary of the National Institutes of Health-international work-shop. Hepatology 1982;2:879-84.
26. Trotman BW. Insights into pigment stone disease. J Lab Clin Med 1979;93:349-52.
27. Watson J, Lichtman HC, Shapiro HD. Splenomegaly in sickle cell anemia. Am J Med 1956;20:196-206.
28. Stevens Jr. AR. Splenectomy in sickle cell anemia. Arch Intern Med 1970;125:883-4.
29. Adekile AD, McKie KM, Adeodu OO, et al. Spleen in sickle cell anemia: Comparative studies of Nigerian and U.S. patients. Am J Hematol 1993;42:316-21.
30. Al-Salem AH, Qaisaruddin S, Al Jam'a A, et al. Splenic abscess and sickle cell disease. Am J Hematol 1998;58:100-4.
31. Cavenagh JD, Joseph AE, Dilly S, et al. Splenic sepsis in sickle cell disease. Br J Haematol 1994;86:187-9.
32. Chuang E, Ruchelli E, Mulberg AE. Autoimmune liver disease and sickle cell anemia in children: A report of three cases. J Pediatr Hematol Oncol 1997;19:159-62.
33. Hillmen P, Lewis SM, Bessler M, et al. Natural history of paroxysmal nocturnal hemoglobinuria. N Engl J Med 1995;333:1253-8.
34. Socie G, Mary JY, de Gramont A, et al. Paroxysmal nocturnal haemoglobinuria: Long-term follow-up and prognostic factors. Lancet 1996;348:573-7.
35. Ware RE, Hall SE, Rosse WF. Paroxysmal nocturnal hemoglobinuria with onset in childhood and adolescence. N Engl J Med 1991;325:991-6.
36. Rosse WF. Paroxysmal nocturnal hemoglobinuria as a molecular disease. Medicine (Baltimore) 1997;76:63-93.
37. Takeda J, Miyata T, Kawagoe K, et al. Deficiency of the GPI anchor caused by somatic mutation of the P1G-A gene in paroxysmal nocturnal hemoglobinuria. Cell 1993;73:703-11.
38. Pramoonjago P, Pakdeesuwan K, Siripanyophinyo U, et al. Genotypic, immunophenotypic and clinical features of Thai patients with paroxysmal nocturnal hemoglobinuria. Br J Haematol 1999;105:497-504.
39. Le XF, Yang TY, Yang XY, et al. Characteristics of paroxysmal nocturnal hemoglobinuria in China: Clinical analysis of 476 cases. Chinese Med J 1990;103:885-9.
40. Ray JG, Burows RF, Ginsberg JS, et al. Paroxysmal nocturnal hemoglobinuria and the risk of venous thrombosis: Review and recommendations for management of the pregnant and nonpregnant patient. Haemostasis 2000;30:103-17.
41. Tomizuka H, Hatake K, Kitagawa S, et al. Portal vein thrombosis in paroxysmal nocturnal haemoglobinuria. Acta Haematol 1999;101:149-52.
42. Arrive L, Menu Y, Dessarts I, et al. Diagnosis of abdominal venous thrombosis by means of spin-echo and gradient-echo MR imaging: Analysis with receiver operating characteristic curves. Radiology 1991;181:661-8.
43. Mathieu D, Rahmouni A, Villeneuve P, et al. Impact of magnetic resonance imaging on the diagnosis of abdominal complications of paroxysmal nocturnal hemoglobinuria. Blood 1996;85:3283-8.
44. Slakey DP, Klein AS, Venbrux AC, et al. Budd-Chiari syndrome: Current management options. Ann Surg 2001;233:522-7.
45. Valla D, Dhumeaux D, Babany G, et al. Hepatic vein thrombosis in paroxysmal nocturnal hemoglobinuria: A spectrum from asymptomatic occlusion of hepatic venules to fatal Budd-Chiari syndrome. Gastroenterol 1987;93:569-75.
46. Graham ML, Rosse WF, Halperin EC, et al. Resolution of Budd-Chiari syndrome following bone marrow transplantation for paroxysmal nocturnal hemoglobinuria. Br J Haematol 1996;92:707-10.
47. Beutler E. Glucose-6-phosphate dehydrogenase deficiency. N Engl J Med 1991;324:169-74.
48. Beutler E. The genetics of glucose-6-phosphate dehydrogenase deficiency. Semin Hematol 1990;27:137-64.
49. Heller P, Best WR, Nelson RB, et al. Clinical implications of sickle cell trait and glucose-6-phosphate dehydrogenase deficiency in hospitalized black male patients. N Engl J Med 1979;300:1001-5.
50. Vulliamy T, Luzzatto L, Hirono A, et al. Hematologically important mutations: Glucose-6-phosphate dehydrogenase deficiency. Blood Cells Mol Dis 1997;23:302-13.
51. Beutler E, Dem RJ, Alving AS. The hemolytic effect of primaquine. IV. The relationship of cell age to hemolysis. J Lab Clin Med 1954;44:439-42.
52. Lumeng L, O'Connor KW. Differential diagnosis of jaundice. In: Ostrow JD, editor. Bile Pigments and Jaundice. New York: Marcel Dekker; 1986. p. 475.
53. Kaplan M, Hammerman C, Beutler E. Hyperbilirubinaemia, glucose-6-phosphate dehydrogenase deficiency and Gilbert syndrome. Eur J Pediatr 2001;160:195.
54. Kaplan M, Renbaum P, Levy-Lahad E, et al. Gilbert syndrome and glucose-6-phosphate dehydrogenase deficiency: A dose-dependent genetic interaction crucial to neonatal hyperbilirubinemia. Proc Natl Acad Sci U S A 1997;94:12128-32.
55. Beutler E. G6PD: Population genetics and clinical manifestations. Blood Rev 1996;10:45-52.
56. Sullivan DW, Glader BE. Hereditary spherocytosis. Pediatr Ann 1980;9:308-11.
57. Weed RI. Hereditary spherocytosis: A review. Arch Intern Med 1975;135:1316-23.
58. Godal HC, Heisto H. High prevalence of increased osmotic fragility of red blood cells among Norwegian blood donors. Scand J Haematol 1981;27:30-4.
59. Jensson O, Jonasson JL, Magnusson S. Studies on HS in Iceland. Scand J Hematol 1977;201:187-95.
60. Morton NE, Mackinney AA, Kosower N, et al. Genetics of spherocytosis. Semin Hematol 1962;14:170-84.
61. Eber SW, Armbrust R, Schröter W. Variable clinical severity of hereditary spherocytosis: Relation to erythrocytic spectrim concentration, osmotic fragility, and autohemolysis. J Pediatr 1990;117:409-16.
62. Gallagher PG, Forget BG. Hematologically important mutations: Spectrin and ankyrin variants in hereditary spherocytosis. Blood Cells Mol Dis 1998;24:539-43.
63. Miraglia del Giudice E, Francese M, Nobili B, et al. High frequency of de novo mutations in ankyrin gene (ANK1) in children with hereditary spherocytosis. J Pediatr 1998;132:117-20.
64. Jonte F, Ramirez A, Medina J, et al. Hereditary spherocytosis: Clinical characteristics and treatment with splenectomy. Sangre (Barc) 1995;40:45-8.
65. Krueger HC, Burgert EO. Hereditary spherocytosis in 100 children. Mayo Clin Proc 1966;41:821-30.
66. Evans EA, Waugh R, Melnik L. Elastic area compressability modulus of red cell membrane. Biophys J 1976;16:585-95.
67. Gairdner D. The association of gall-stones with acholuric jaundice in children. Arch Dis Child 1939;14:109-20.
68. Lux SE, Palek J. Disorders of the red cell membrane. In: Handin RI, Lux SE, Stossel TP, editors. Blood: Principles and Practice of Hematology. Philadelphia: JB Lippincott; 1995. p. 1701.
69. Bates GC, Brown CH. Incidence of gallbladder disease in chronic hemolytic anemia (spherocytosis). Gastroenterol 1952;21:104-9.
70. Croom 3rd RD, McMillan CW, Sheldon GF, et al. Hereditary spherocytosis: Recent experience and current concepts of pathophysiology. Ann Surg 1986;203:34-9.
71. Young LE, Izzo MJ, Platzer RF. Hereditary spherocytosis. I. Clinical, hematologic and genetic features in 28 cases, with particular reference to the osmotic and mechanical fragility of incubated erythrocytes. Blood 1951;6:1073-98.
72. del Guidice EM, Perrotta S, Nobili B, et al. Coinheritance of Gilbert syndrome increases the risk for developing gallstones in patients with hereditary spherocytosis. Blood 1999;94:2259-62.
73. Holcomb Jr. GW, Holcomb 3rd GW. Cholelithiasis in infants, children, and adolescents. Pediatr Rev 1990;11:268-74.
74. Ransohoff DF, Gracie WA. Treatment of gallstones. Ann Intern Med 1993;119:606-19.
75. Edwards CQ, Skolnick MH, Dadone MM, et al. Iron overload in hereditary spherocytosis: Association with HLA-linked hemochromatosis. Am J Hematol 1982;13:101-9.
76. Fargion S, Cappellini MD, Pipemo A, et al. Association of hereditary spherocytosis and idiopathic hemochromatosis: A synergistic effect in determining iron overload. Am J Clin Pathol 1986;86:645-9.
77. Mohler DN, Wheby MS. Hemochromatosis heterozygotes may have significant iron overload when they also have hereditary spherocytosis. Am J Med Sci 1986;292:320-4.
78. Barry M, Scheuer PJ, Sherlock S, et al. Hereditary spherocytosis with secondary haemochromatosis. Lancet 1968;2:481-5.
79. Takegoshi T, Nishino T, Tanino M, et al. An autopsy case of hemochromatosis and hepatoma combined with hereditary hemochromatosis. Jpn J Med 1984;23:48-52.
80. Patton ML, Moss BE, Haith Jr. LR, et al. Concomitant laparoscopic cholecystectomy and splenectomy for surgical management of hereditary spherocytosis. Am Surg 1997;63:536-9.
81. Trias M, Taragona EM. Laparoscopic treatment of hereditary spherocytosis (splenectomy plus cholecystectomy). J Laparoendosc Surg 1994;4:71-3.
82. Yamagishi S, Watanabe T. Concomitant laparoscopic splenectomy and cholecystectomy for management of hereditary spherocytosis associated with gallstones. J Clin Gastroenterol 2000;30:447.
83. National High Blood Pressure Education Program. Working group report on high blood pressure in pregnancy. Am J Obstet Gynecol 2000;183:S1-S22.
84. Campbell DM, MacGillivray I. Preeclampsia in twin pregnancies: Incidence and outcome. Hypertens Pregnancy 1999;18:197-207.
85. Hauth JC, Ewell MG, Levine RJ, et al. Pregnancy outcomes in healthy nulliparas who developed hypertension: Calcium for Preeclampsia Prevention Study Group. Obstet Gynecol 2000;95:24-8.
86. Knuist M, Bonsel GJ, Zondervan HA, et al. Intensification of fetal and maternal surveillance in pregnant women with hypertensive disorders. Int J Gynaecol Obstet 1998;61:127-33.
87. Sibai BM, Hauth J, Caritis S, et al. Hypertensive disorders in twin versus singleton pregnancies: National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. Am J Obstet Gynecol 2000;182:938-44.
88. Ferraz EM, Sherline DM. Convulsive toxemia of pregnancy (eclampsia). South Med J 1976;69:152-6.
89. Moller B, Lindmark G. Eclampsia in Sweden, 1976-1980. Acta Obstet Gynaecol Scand 1986;65:307-14.
90. Martin Jr JN, Blake PG, Perry Jr KG, et al. The natural history of HELLP syndrome: Patterns of disease progression and regression. Am J Obstet Gynecol 1991;164:1500-13.
91. Sibai BM. The HELLP syndrome (hemolysis, elevated liver enzymes, and low platelets): Much ado about nothing? Am J Obstet Gynecol 1990;162:311-6.
92. Weinstein L. Syndrome of hemolysis, elevated liver enzymes, and low platelet count: A severe consequence of hypertension in pregnancy. Am J Obstet Gynecol 1982;142:159-67.
93. Sibai BM, Ramadan MK, Usta I, et al. Matemal morbidity and mortality in 442 pregnancies with hemolysis, elevated liver enzymes, and low platelets (HELLP syndrome). Am J Obstet Gynecol 1993;169:1000-6.
94. Jones SL. HELLP! A cry for laboratory assistance: A comprehensive review of the HELLP syndrome highlighting the role of the laboratory. Hematopathol Mol Hematol 1998;11:147-71.
95. Wilke G, Rath W, Schutz E, et al. Haptoglobin as a sensitive marker of hemolysis in HELLP syndrome. Int J Gynaecol Obstet 1992;39:29-34.
96. Zusterzeel PL, te Morsche R, Raijmakers MT, et al. Gilbert's syndrome is not associated with HELLP syndrome. Br J Obstet Gynaecol 2001;108:1003-4.
97. Barton JR, Sibai BM. Hepatic imaging in HELLP syndrome (hemolysis, elevated liver enzymes, and low platelet count). Am J Obstet Gynecol 1996;174:1820-7.
98. Barton JR, Riely CA, Adamec TA, et al. Hepatic histopathologic condition does not correlate with laboratory abnormalities in HELLP syndrome (hemolysis, elevated liver enzymes, and low platelet count). Am J Obstet Gynecol 1992;167:1538-43.
99. Halim A, Kanayama N, El Maradny E, et al. Immunohistological study in cases of HELLP syndrome (hemolysis, elevated liver enzymes and low platelets) and acute fatty liver of pregnancy. Gynecol Obstet Invest 1996;41:106-12.
100. Audibert F, Friedman SA, Frangieh AY, et al. Clinical utility of strict diagnostic criteria for the HELLP (hemolysis, elevated liver enzymes, and low platelets) syndrome. Am J Obstet Gynecol 1996;175:460-4.
101. Leduc L, Wheeler JM, Kirshon B, et al. Coagulation profile in severe preeclampsia. Obstet Gynecol 1992;79:14-8.
102. Magee LA, Omstein MP, von Dadelszen P. Management of hypertension in pregnancy. BMJ 1999;318:1332-6.
103. Saudan P, Brown MA, Buddle ML, et al. Does gestational hypertension become pre-eclampsia? Br J Obstet Gynaecol 1998;105:1177-84.
104. Sibai BM, Taslimi MM, El-Nazer A, et al. Matemal-perinatal outcome associated with the syndrome of hemolysis, elevated liver enzymes, and low platelets in severe preeclampsiaeclampsia. Am J Obstet Gynecol 1986;155:501-9.
105. Smith Jr. LG, Moise Jr. KJ, Dildy 3rd GA, et al. Spontaneous rupture of liver during pregnancy: Current therapy. Obstet Gynecol 1991;77:171-5.
106. Haddad B, Barton JR, Livingston JC, et al. Risk factors for adverse matemal outcomes among women with HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome. Am J Obstet Gynecol 2000;183:444-8.
107. Sibai BM, Ramadan MK, Chari RS, et al. Pregnancies complicated by HELLP syndrome (hemolysis, elevated liver enzymes, and low platelets): Subsequent pregnancy outcome and long-term prognosis. Am J Obstet Gynecol 1995;172:125-9.
108. Sullivan CA, Magann EF, Perry Jr. KG, et al. The recurrence risk of the syndrome of hemolysis, elevated liver enzymes, and low platelets (HELLP) in subsequent gestations. Am J Obstet Gynecol 1994;171:940-3.
109. Reck T, Bussenius-Kammerer M, Ott R, et al. Surgical treatment of HELLP syndrome-associated liver rupture - An update. Eur J Obstet Gynecol Reprod Biol 2000;99:57-65.
110. Strate T, Broering DC, Bloechle C, et al. Orthotopic liver transplantation for complicated HELLP syndrome: Case report and review of the literature. Arch Gynecol Obstet 2000;264:108-11.